[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-366577-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-366577-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multiple-roles-and-mechanisms-of-muc6-in-cancer-review","Multiple roles and mechanisms of MUC6 in cancer - Review","","Mucin 6 (MUC6) is primarily expressed in gastrointestinal epithelium and belongs to the mucin family, featuring a protein backbone with extensive glycosylation that supports epithelial barrier integrity. Evidence indicates that MUC6 glycosylation influences cancer development, diagnosis, therapy, and prognosis, particularly in gastric, pancreatic, and colorectal malignancies. The review synthesizes current findings on MUC6 functions across cancers and highlights roles in biomarker potential and tumor susceptibility assessment. Validation requires large multicenter studies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multiple-roles-and-mechanisms-of-muc6-in-cancer-review/366577/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multiple-roles-and-mechanisms-of-muc6-in-cancer-review/366577.png","ImageObject",300,407,{"name":42,"@type":43},"Franzy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is MUC6 and where is it mainly expressed?","Question",{"text":63,"@type":64},"MUC6 is a mucin family member characterized by a protein backbone with extensive glycosylation. It is primarily expressed in the gastrointestinal (GI) epithelium and contributes to epithelial barrier integrity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does MUC6 glycosylation relate to cancer?",{"text":68,"@type":64},"The review explains that cancer-associated changes in mucin glycosylation can enhance tumor immune evasion or immunosuppression. MUC6 glycosylation is linked to cancer development, diagnosis, therapy, and prognosis, especially in GI malignancies.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is MUC6 considered a potential biomarker for cancer?",{"text":72,"@type":64},"The abstract notes that loss of MUC6 expression can associate with gastric cancer risk, while upregulation may support biomarker value in prostate cancer biopsy. It also highlights MUC6 glycoforms and tandem repeat polymorphisms as potential tools for cancer susceptibility assessment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},366577,1790310905,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336478945519,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","INTERNATIONAL JOURNAL OF MOLEcULAR MEdIcINE 56: 188, 2025  \nMultiple roles and mechanisms of MUC6 in cancer (Review)  \nXIN LUO, XIAO FU, YING XIONG and PING XIAO  \nDepartment of General Practice, The Second Affiliated Hospital, Jiangxi Medical College,  \nNanchang University, Nanchang, Jiangxi 330008, P.R. china  \nReceived May 6, 2025; Accepted July 22, 2025  \ndOI: 10.3892/ijmm.2025.5629  \nAbstract. Mucin 6 (MUc6), primarily expressed in the gastrointestinal (GI) epithelium, is a member of the mucin family characterized by a protein backbone with extensive glycosylation, playing a crucial role in preserving epithelial barrier integrity. Accumulating evidence indicates that MUc6 glycosylation contributes significantly to cancer development, diagnosis, therapy and prognosis‑particularly in GI malignan‑ cies such as gastric, pancreatic and colorectal cancers. In the present review, current findings on the multifaceted roles of MUc6 across various cancers were comprehensively summa‑ rize. For instance, loss of MUc6 expression is frequently associated with gastric cancer risk, while its upregulation may serve as a valuable biomarker in prostate cancer biopsy, aiding in early detection. Additionally, the identification of MUC6‑Tnglycoforms offers promising avenues for novel therapeutic strategies . The distinctive tandem repeat polymorphisms within the MUc6 gene further suggest its potential utility in assessing cancer susceptibility based on allele length varia‑ tion. These insights underscore the relevance of MUc6 in both mechanistic research and clinical oncology. Although prelimi‑ nary data are encouraging, large‑scale, multicenter studies are necessary to fully validate the clinical application of MUc6 as a biomarker for cancer staging and prognosis. Finally, the present review outlines future directions for exploring MUc6 in the context of cancer therapy development.  \nCorrespondence to: dr Ping Xiao, department of General Practice, The Second Affiliated Hospital, Jiangxi Medical college, Nanchang University, 1 Minde Road, donghu, Nanchang, Jiangxi 330008, P.R. china  \nE‑mail: [13979127982@163.com](13979127982@163.com)  \nAbbreviations: PTS, proline, threonine and serine; VNTR, variable number tandem repeat region; TLR7, Toll‑like receptor 7; vWF, von Willebrand factor; ppGalNAc‑Ts, polypeptide N‑acetylgalactosamine transferases; α‑1,4‑GlcNAc, α‑1,4‑linked N‑acetylglucosamine; SSA/P, sessile serrated adenomas also termed sessile serrated polyps; SSA/Pd, SSA/Ps with dysplasia; HPPs, hyperplastic polyps; TFF2, trefoil factor family 2; lncRNA, long non‑coding RNA; cASc2, cancer susceptibility candidate 2  \nKey words: MUc6, gastrointestinal tumors, mucin, glycosylation, tumor biomarkers, immunotherapy  \nContents  \n1. Introduction  \n2. Structure and basic functions of MUc6  \n3. MUc6 in common digestive tract tumors  \n4. In other cancers  \n5. The role of MUc6 in tumor immunotherapy  \n6. conclusions  \n1. Introduction  \nMucins, major components of mucus, are a family of high‑molecular‑weight proteins that are rich in proline, threonine and serine (PTS) residues and contain numerous O‑glycosylation sites (1,2) . common mucins can be catego‑ rized into two types, secreted mucins and membrane‑bound mucins, which form a selective protective barrier on epithelial surfaces and perform other physiological functions (3) . In general, mucins consist of a core protein backbone and highly complex glycosylations (4) . The glycan chains are linked to serine or threonine residues by O‑glycosylation to form N‑acetylgalactosamine (GalNAc) attached to the core poly‑ peptide backbone (5) . Additionally, mucins have numerous tandem repeats, especially around glycosylation sites, which allow mucins to carry massive glycan chains, resulting in their unique adhesive and protective functions (1,6,7) . There are currently 22 known human genes encoding mucins, but there are likely additional mucin proteins waiting to be discov‑ ered (8‑11) .  \nMucins are genera","cbCaieRM12JPYDSR","https://ap.wps.com/l/cbCaieRM12JPYDSR","pdf",1900601,14,"English","# Introduction\n# Structure and basic functions of MUc6\n# MUc6 in common digestive tract tumors\n# In other cancers\n# The role of MUc6 in tumor immunotherapy\n# Conclusions","[{\"question\":\"What is MUC6 and where is it mainly expressed?\",\"answer\":\"MUC6 is a mucin family member characterized by a protein backbone with extensive glycosylation. It is primarily expressed in the gastrointestinal (GI) epithelium and contributes to epithelial barrier integrity.\"},{\"question\":\"How does MUC6 glycosylation relate to cancer?\",\"answer\":\"The review explains that cancer-associated changes in mucin glycosylation can enhance tumor immune evasion or immunosuppression. MUC6 glycosylation is linked to cancer development, diagnosis, therapy, and prognosis, especially in GI malignancies.\"},{\"question\":\"Why is MUC6 considered a potential biomarker for cancer?\",\"answer\":\"The abstract notes that loss of MUC6 expression can associate with gastric cancer risk, while upregulation may support biomarker value in prostate cancer biopsy. It also highlights MUC6 glycoforms and tandem repeat polymorphisms as potential tools for cancer susceptibility assessment.\"}]","Multiple roles and mechanisms of MUC6 in cancer - Review | PDF",1790166202,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92cf019cecd574d798e556fbba243dc8.webp",983,1357,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d12b1143d576cfc689584d708b46dbb.webp",982,1356,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16433cd7855b2a3b2fbd8e829f314e19.webp",981,1354,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8e5bc1e855d326e74fb14e55cc31828.webp",980,1353]